-+ 0.00%
-+ 0.00%
-+ 0.00%

Needham Maintains Buy on Hims & Hers Health, Raises Price Target to $42

Benzinga·08/11/2026 11:37:36
Listen to the news
Needham analyst Ryan MacDonald maintains Hims & Hers Health (NYSE:HIMS) with a Buy and raises the price target from $35 to $42.